Renaissance Technologies’s Rain Oncology Inc. Common Stock RAIN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,100
Closed -$13K 4225
2023
Q4
$13K Buy
+11,100
New +$12K ﹤0.01% 3623
2023
Q2
Sell
-41,100
Closed -$359K 4377
2023
Q1
$359K Sell
41,100
-9,000
-18% -$83.2K ﹤0.01% 3041
2022
Q4
$401K Buy
50,100
+28,100
+128% +$176K ﹤0.01% 3078
2022
Q3
$107K Buy
22,000
+7,000
+47% +$43.9K ﹤0.01% 3578
2022
Q2
$83K Buy
+15,000
New +$51.5K ﹤0.01% 3893

Renaissance Technologies's RAIN Position: Q1 2024 in Review

Renaissance Technologies sold out of Rain Oncology Inc. Common Stock (RAIN) in Q1 2024, closing a stake of 11,100 shares — an estimated $13K sold.

Renaissance Technologies first reported a position in RAIN in Q2 2022 and held it in 5 quarters. The position peaked at $401K in Q4 2022. 0 funds tracked by Wall St. Rank hold RAIN as of Q1 2024.

  • Renaissance Technologies reported no remaining Rain Oncology Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Renaissance Technologies sold 11,100 Rain Oncology Inc. Common Stock shares in Q1 2024, an estimated $13K.
  • Renaissance Technologies first reported a position in Rain Oncology Inc. Common Stock in Q2 2022 and held it in 5 quarters.
  • Renaissance Technologies's Rain Oncology Inc. Common Stock position peaked at $401K in Q4 2022.
  • 0 funds tracked by Wall St. Rank held Rain Oncology Inc. Common Stock as of Q1 2024.

Based on Renaissance Technologies's 13F filing for Q1 2024, filed 13 May 2024.